Xpress Biologics

Xpress Biologics

Foundation date

14/04/2014

Sector

#Biotechnology / R&D Services

Subsector

• #R&D Services - CRO (Contract Research Organization)

Therapeutic areas

• #Cardiovascular
• #Conditions originating in the perinatal period
• #Congenital malformations - deformations and chromosomal abnormalities
• #Digestive system
• #Diseases of the blood and blood-forming organs - immune disorders
• #Diseases of the ear
• #Diseases of the eye
• #Diseases of the nervous system
• #Endocrine - nutritional and metabolic diseases
• #External causes of morbidity and mortality
• #Genitourinary system
• #Infectious and parasitic diseases
• #Injury - poisoning and certain other consequences of external causes
• #Mental and behavioural disorders
• #Musculoskeletal system and connective tissue
• #Neoplasms / cancer / oncology
• #Pregnancy - childbirth and the puerperium
• #Respiratory system
• #Skin and subcutaneous tissue
• #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified

Xpress Biologics is a contract development organization specialized in the production of Biologics, proteins and DNA, for preclinical applications specific to the therapeutic and diagnostic markets.Its mission is to enable the transition of the projects from R&D to clinical manufacturing.The production scale and the quality of the biologics (R&D and GLP grade material) are adapted for in vitro and in vivo pre-clinical validation of the biologics.